IFNγ primes macrophages for inflammatory activation by high molecular weight hyaluronan

Cellular Immunology

Volumn 262, Issue 2, 2010, Pages 84-88

  Wallet, Mark A ^a   Wallet, Shannon M ^b   Guiulfo, Giorgio ^a   Sleasman, John W ^c   Goodenow, Maureen M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

C Jun; Hyaluronan; Inflammation; Interferon gamma; Interleukin 10; Interleukin 12; Macrophages; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

E1A PROTEIN; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C JUN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROMOLECULE; MACROPHAGE ACTIVATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TH1 CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; JOINT; MACROPHAGE; METABOLISM; PATHOLOGY;

CELLS, CULTURED; CYTOKINES; HUMANS; HYALURONIC ACID; INFLAMMATION; INTERFERON-GAMMA; JOINTS; MACROPHAGE ACTIVATION; MACROPHAGES; MOLECULAR WEIGHT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950863541     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.02.013     Document Type: Article

References (20)

1. Bastow E., Byers S., Golub S., Clarkin C., Pitsillides A., Fosang A. Hyaluronan synthesis and degradation in cartilage and bone. Cell. Mol. Life Sci. 2008, 65:395-413.
2. Chang E., Kim H., Ha J., Ryu J., Park K., Kim U., Lee Z., Kim H., Fisher D., Kim H. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J. Cell Sci. 2007, 120:166-176.
3. Muto J., Yamasaki K., Taylor K., Gallo R. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol. Immunol. 2009, 47:449-456.
4. Lajeunesse D., Delalandre A., Martel-Pelletier J., Pelletier J. Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts. Bone 2003, 33:703-710.
5. Altman R. Status of hyaluronan supplementation therapy in osteoarthritis. Curr. Rheumatol. Rep. 2003, 5:7-14.
6. Brennan F., Beech J. Update on cytokines in rheumatoid arthritis. Curr. Opin. Rheumatol. 2007, 19:296-301.
7. Hamilton J., Tak P. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 2009, 60:1210-1221.
8. McInnes I., Liew F. Cytokine networks-towards new therapies for rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2005, 1:31-39.
9. Schulze-Koops H., Kalden J. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2001, 15:677-691.
10. Duke O., Panayi G., Janossy G., Poulter L. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin. Exp. Immunol. 1982, 49:22-30.
11. Hu X., Chakravarty S., Ivashkiv L. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 2008, 226:41-56.
12. Gendelman H., Orenstein J., Martin M., Ferrua C., Mitra R., Phipps T., Wahl L., Lane H., Fauci A., Burke D. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 1988, 167:1428-1441.
13. Ochiai M., Tamura H., Yamamoto A., Aizawa M., Kataoka M., Toyoizumi H., Hroiuchi Y. A limulus amoebocyte lysate activating activity (LAL activity) that lacks biological activities of endotoxin found in biological products. Microbiol. Immunol. 2002, 46:527-533.
14. Katsikis P., Chu C., Brennan F., Maini R., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 1994, 179:1517-1527.
15. Pitsillides A., Worrall J., Wilkinson L., Bayliss M., Edwards J. Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br. J. Rheumatol. 1994, 33:5-10.
16. Georganas C., Liu H., Perlman H., Hoffmann A., Thimmapaya B., Pope R. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J. Immunol. 2000, 165:7199-71206.
17. Baek Y., Haas S., Hackstein H., Bein G., Hernandez-Santana M., Lehrach H., Sauer S., Seitz H. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol. 2009, 10:18.
18. Feng H., Cheng T., Steer J., Joyce D., Pavlos N., Leong C., Kular J., Liu J., Feng X., Zheng M., Xu J. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J. Biol. Chem. 2009, 284:14667-14676.
19. Huang Q., Ma Y., Adebayo A., Pope R. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum 2007, 56:2192-2201.
20. Herrero C., Hu X., Li W., Samuels S., Sharif M., Kotenko S., Ivashkiv L. Reprogramming of IL-10 activity and signaling by IFN-gamma. J. Immunol. 2003, 171:5034-5041.